✦ LIBER ✦

Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

✍ Scribed by Ogawa, Eiichi; Furusyo, Norihiro; Kajiwara, Eiji; Takahashi, Kazuhiro; Nomura, Hideyuki; Maruyama, Toshihiro; Tanabe, Yuichi; Satoh, Takeaki; Nakamuta, Makoto; Kotoh, Kazuhiro; Azuma, Koichi; Dohmen, Kazufumi; Shimoda, Shinji; Hayashi, Jun

Book ID: 121373431
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 779 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2012.10.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P279 Reduction of hepatocellular carcino

P279 Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients

✍ Furusyo, N.; Murata, M.; Ogawa, E.; Nomura, H.; Hayashi, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Treatment of chronic hepatitis C in HIV

Treatment of chronic hepatitis C in HIV infected patients (PTS) with pegylated interferon alpha 2B (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2B

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

The efficacy and safety of pegylated int

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial

✍ Jee-Fu Huang; Ming-Lung Yu; Chung-Feng Huang; Chang-Fu Chiu; Chia-Yen Dai; Ching 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 806 KB

1145 IMPACT OF PEGYLATED INTERFERON a2B

1145 IMPACT OF PEGYLATED INTERFERON a2B PLUS RIBAVIRIN TREATMENT FOR CHRONIC HEPATITIS C PATIENTS WITH HISTORY OF HEPATOCELLULAR CARCINOMA

✍ Ogawa, E.; Furusyo, N.; Kajiwara, E.; Takahashi, K.; Nomura, H.; Tanabe, Y.; Sat 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Efficacy of pegylated interferon alpha-2

Efficacy of pegylated interferon alpha-2B in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment

✍ M. Chousterman; V. Auray-Cartier; H. Hagege; J.P. Arpurt; P. Cassan; J. Denis; D 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 325 KB

Detection of hepatocellular carcinoma du

Detection of hepatocellular carcinoma during the treatment with pegylated interferon alfa-2a and ribavirin for chronic hepatitis C

✍ M. Capanni; E. Lorefice; M.C. Benini; M.R. Biagini; A. Tozzi; A. Galli; C. Surre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB